Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Wilms Tumor × Vincristine × Clear all

Phase

Phase 2 5 Phase 3 3 Phase 1 2 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lymphoma, Large B-Cell, Diffuse 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Lymphoma 12 Lymphoma, Non-Hodgkin 10 Lymphoma, Mantle-Cell 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, Follicular 6 Lymphoma, B-Cell 6 Burkitt Lymphoma 6 Immunoblastic Lymphadenopathy 5 Rhabdomyosarcoma 4 Lymphoma, Large-Cell, Anaplastic 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia 4 Recurrence 3 Lymphoma, Primary Effusion 3 Sarcoma, Ewing 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Plasmablastic Lymphoma 2 Osteosarcoma 2 Neuroblastoma 2 Neoplasms 2 Myelodysplastic Syndromes 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Hodgkin Disease 2 Enteropathy-Associated T-Cell Lymphoma 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1

Interventions

Temozolomide 3 Filgrastim 2 Drug Therapy 2 talazoparib 1 sargramostim 1 pembrolizumab 1 oblimersen 1 irinotecan sucrosofate 1 entrectinib 1 X-Rays 1 Vincristine 1 Specimen Handling 1 Radiosurgery 1 Proteasome Inhibitors 1 Phantoms, Imaging 1 Peripheral Blood Stem Cell Transplantation 1 Nivolumab 1 Monatide (IMS 3015) 1 Lenalidomide 1 Isotretinoin 1 Irinotecan 1 Immunomodulating Agents 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Etoposide 1 Docetaxel 1 Cyclophosphamide 1 Bortezomib 1 Bone Density 1 Beclomethasone 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05384821 2026-03-18

MetroWilms

Centre Oscar Lambret

Phase 1/2 Recruiting

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡